Melanotan II (MT2) 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Melanotan II supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF112025065

Key analytical results include:

• Assay Content: 11.22 mg
• Identification – Retention Time: 0.998
• Identification – Spectrum: 996
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Melanotan II is a synthetic peptide research compound frequently studied in controlled laboratory environments investigating melanocortin receptor signalling and peptide-mediated regulatory pathways.

The compound belongs to a class of melanocortin receptor agonists derived from the naturally occurring hormone alpha-melanocyte-stimulating hormone (α-MSH).

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, Melanotan II has become a compound frequently referenced in experimental melanocortin signalling research models.

Compound Overview

Melanotan II, often abbreviated as MT-2, is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), a peptide involved in melanocortin receptor signalling.

The compound is commonly studied in biochemical research examining receptor interactions within the melanocortin signalling system.

Experimental models often focus on the compound’s interaction with multiple melanocortin receptor subtypes including MC1R, MC3R, MC4R and MC5R.

These receptor systems are involved in peptide hormone signalling networks and intracellular regulatory processes studied within controlled laboratory environments.

Historical Background and Scientific Context

Scientific interest in melanocortin receptor biology expanded rapidly during the late twentieth century as peptide hormone research advanced.

Researchers investigating alpha-melanocyte-stimulating hormone began developing synthetic analogues designed to interact with melanocortin receptors in controlled experimental systems.

During the 1990s Melanotan II emerged as a synthetic peptide analogue used in experimental studies examining receptor signalling within the melanocortin pathway.

Since that time the compound has been referenced in various laboratory models exploring melanocortin receptor activity and peptide-mediated biochemical signalling.

Mechanistic Focus in Research

Within experimental laboratory settings, Melanotan II is commonly studied in relation to melanocortin receptor activation and peptide signalling dynamics.

Research investigations frequently explore the compound in experimental models examining:

• Melanocortin receptor signalling pathways
• MC1R receptor activation dynamics
• MC3R and MC4R receptor interaction studies
• Peptide hormone signalling networks
• Comparative melanocortin agonist research
• Cellular receptor signalling systems
• Peptide-mediated intracellular regulatory processes

These experimental models allow scientists to investigate molecular signalling mechanisms involved in melanocortin receptor pathways.

Research Applications

In controlled research environments, Melanotan II may be utilised in experimental models designed to explore melanocortin receptor signalling and peptide hormone regulatory pathways.

Examples of research applications include:

• Melanocortin receptor signalling research
• Peptide hormone interaction studies
• Pigmentation pathway investigation
• Cell signalling analysis
• Comparative receptor agonist evaluation
• Biochemical peptide research
• Controlled in vitro receptor signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Purity 99.8% with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin level below 0.001 EU per mg
• Batch GF112025065 – Published November 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.